TGF-β signaling derived from cancer cells or stromal cells initiates the differentiation of fibroblasts into myofibroblasts by inducing SMAD2 activity and contributes to malignant progression, especially distant metastasis [31, 56]. The gene discussed is SMAD2; the disease is cancer.